Investors

Harnessing the therapeutic power of cannabinoids

Chair's Welcome

Welcome to OCT.

Engaging with our investors is very important to us and we want you to be well briefed about the Company, our activities and our drug development programmes.

Business model & strategy

Click ‘learn more’ for a breakdown of our business model and strategy.

Annual report & interim results

Click ‘learn more’ for our annual reports and interim results.

Our People

Click ‘learn more’ for details on our team.

Research reports

Corporate governance

Key documents

Investor Q&A